Simon M
Senior Member (Voting Rights)
and this puts an enormous question mark over the study.According to the results, 4.5% post-COVID-19 participants met ME/CFS diagnostic criteria, compared to 0.6% participants that had not been infected by SARS-CoV-2 virus
The highest credible prevalence rates we have for ME/CFS, from the recent Samms/Ponting study, is 0.6%. Seems hard to believe they found the same rate of NEW cases a year in the non-Covid control group Something doesn’t add up. You would expect incidence to be so much lower than prevalence.
Last edited: